Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Feb 2018| TMR178A| Transparency

Report Highlights

Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market: Overview

The report on the exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market analyzes the current and future scenario of the global market. Rise in the prevalence of cystic fibrosis and chronic pancreatitis, and increase in prevalence of diabetes across the world are the major drivers of the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market.

The exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market with respect to the segments based on therapeutics & diagnostics types, and geography. A detailed qualitative analysis of drivers and restraints of the market and its opportunities have been provided in the market overview section. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market.

Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market: Segmentation

Based on type, the exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market is segmented as therapeutics & diagnostics. The diagnostics segment is again sub-segmented into blood tests, endoscopic ultra-sonography, magnetic resonance imaging [MRI], and CT scanning. The market size and forecast, in terms of value, for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market has been categorized into five major regions and the key countries in the respective regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The country wise market size and analysis for each segment in terms of value has been provided in the report. The research study also covers the competitive scenario in these regions.

Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market: Competitive Dynamics

The report also profiles major players in the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include – Abbvie, Inc., Allergan plc, Nordmark Arzneimittel GmbH & Co. KG, Digestive Care, Inc., Janssen Pharmaceuticals, Inc., Cilian AG, Anthera Pharmaceuticals, Inc., AzurRx Biopharma, Inc. and others.

The global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market is segmented as given below:

Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market, by Type

Therapeutics
Diagnostics
Blood Tests
Endoscopic Ultra-sonography (EUS)
Magnetic Resonance Imaging (MRI)
CT Scanning
Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
Japan
India
China
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC countries
South Africa
Rest of Middle East & Africa

  • Table 1 : U.S. EPI Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, By Brands, 2016–2025
  • Table 2 : EPI Therapeutics Brands in the U.S.
  • Table 3 : Global EPI Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, By Pipeline Products, 2019–2025
  • Table 4 : Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
  • Table 5 : Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
  • Table 6 : Global EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Region, 2015–2025
  • Table 7 : Global EPI Therapeutics Market Value (US$ Mn) Forecast, by Region, 2015–2025
  • Table 8 : Global EPI Diagnostics Market Value (US$ Mn) Forecast, by Region, 2015–2025
  • Table 9 : North America EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 10 : North America EPI Therapeutics Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 11 : North America EPI Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 12 : North America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
  • Table 13 : North America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
  • Table 14 : Europe EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 15 : Europe EPI Therapeutics Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 16 : Europe EPI Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 17 : Europe EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
  • Table 18 : Europe EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
  • Table 19 : Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 20 : Asia Pacific EPI Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 21 : Asia Pacific EPI Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 22 : Asia Pacific EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
  • Table 23 : Asia Pacific EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
  • Table 24 : Latin America EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 25 : Latin America EPI Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 26 : Latin America EPI Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 27 : Latin America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
  • Table 28 : Latin America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
  • Table 29 : Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 30 : Middle East & Africa EPI Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 31 : Middle East & Africa EPI Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 32 : Middle East & Africa EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
  • Table 33 : Middle East & Africa EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
  • Figure 1 : Acronyms
  • Figure 2 : Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) and Distribution, by Region, 2017 and 2025
  • Figure 3 : Global EPI Therapeutics & Diagnostics Market Snapshot, 2016
  • Figure 4 : Market Opportunity Map, 2016
  • Figure 5 : Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 6 : EPI Therapeutics & Diagnostics Market Value Share, by Type (2016)
  • Figure 7 : EPI Therapeutics & Diagnostics Market Value Share, by Diagnostics (2016)
  • Figure 8 : EPI Therapeutics & Diagnostics Market Value Share, by Region (2016)
  • Figure 9 : Total U.S. sales and number of prescriptions of pancreatic enzyme products (PEPs) from 2008-2012 in the United States
  • Figure 10 : Cost per prescription (U.S. Dollars) and number of pancreatic enzyme products (PEPs) marketed in the United States from 2008-12
  • Figure 11 : Drivers and Restraints Snapshot Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Share, by Company, 2016
  • Figure 12 : Global EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
  • Figure 13 : Global EPI Therapeutics & Diagnostics Market Attractiveness Analysis, by Type, 2017–2025
  • Figure 14 : Global EPI Therapeutics & Diagnostics Market Value Share, by Diagnostics, 2017 and 2025
  • Figure 15 : Global EPI Therapeutics & Diagnostics Market Attractiveness, by Diagnostics, 2017–2025
  • Figure 16 : Global Exocrine Pancreatic Insufficiency Market Revenue (US$ Mn) Forecast, by Therapeutics, 2015–2025
  • Figure 17 : Global Exocrine Pancreatic Insufficiency Market Revenue (US$ Mn) Forecast, by Diagnostics, 2015–2025
  • Figure 18 : Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by Blood Tests, 2015–2025
  • Figure 19 : Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by Endoscopic Ultra- sonography (EUS), 2015–2025
  • Figure 20 : Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by Magnetic Resonance Imaging (MRI), 2015–2025
  • Figure 21 : Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by CT Scanning, 2015–2025
  • Figure 22 : Global EPI Therapeutics & Diagnostics Market Value Share, by Region, 2017 and 2025
  • Figure 23 : Global EPI Therapeutics & Diagnostics Market Attractiveness, by Region, 2017–2025
  • Figure 24 : North America EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 25 : North America EPI Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 26 : North America EPI Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 27 : North America EPI Therapeutics & Diagnostics Market Value Share, by Country, 2017 and 2025
  • Figure 28 : North America EPI Therapeutics & Diagnostics Market Attractiveness, by Country, 2017–2025
  • Figure 29 : North America EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
  • Figure 30 : North America EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
  • Figure 31 : Europe EPI Therapeutics & Diagnostics Market Value (US$ Mn), 2015–2025
  • Figure 32 : Europe EPI Therapeutics Market Value (US$ Mn), 2015–2025
  • Figure 33 : Europe EPI Diagnostics Market Value (US$ Mn), 2015–2025
  • Figure 34 : Europe EPI Therapeutics & Diagnostics Market Value Share, by Country, 2017 and 2025
  • Figure 35 : Europe EPI Therapeutics & Diagnostics Market Attractiveness, by Country, 2017–2025
  • Figure 36 : Europe EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
  • Figure 37 : Europe EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
  • Figure 38 : Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 39 : Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Therapeutics, 2015–2025
  • Figure 40 : Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2015–2025
  • Figure 41 : Asia Pacific EPI Therapeutics & Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
  • Figure 42 : Asia Pacific EPI Therapeutics & Diagnostics Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 43 : Asia Pacific EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
  • Figure 44 : Asia Pacific EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
  • Figure 45 : Latin America EPI Therapeutics & Diagnostics Market Value (US$ Mn), 2015–2025
  • Figure 46 : Latin America EPI Therapeutics Market Value (US$ Mn), 2015–2025
  • Figure 47 : Latin America EPI Diagnostics Market Value (US$ Mn), 2015–2025
  • Figure 48 : Latin America EPI Therapeutics & Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
  • Figure 49 : Latin America EPI Therapeutics & Diagnostics Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 50 : Latin America EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
  • Figure 51 : Latin America EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
  • Figure 52 : Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 53 : Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn), by Therapeutics, 2015–2025
  • Figure 54 : Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn), by Diagnostics, 2015–2025
  • Figure 55 : Middle East & Africa EPI Therapeutics & Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
  • Figure 56 : Middle East & Africa EPI Therapeutics & Diagnostics Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 57 : Middle East & Africa EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
  • Figure 58 : Middle East & Africa EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
  • Figure 59 : Global EPI Therapeutics Market Share, by Company, 2016
  • Figure 60 : AbbVie, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
  • Figure 61 : AbbVie, Inc. Breakdown of Net Sales, by Region, 2016
  • Figure 62 : Janssen Pharmaceuticals, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 63 : Janssen Pharmaceuticals, Inc. Breakdown of Net Sales, by Region, 2016
  • Figure 64 : Allergan plc Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
  • Figure 65 : Allergan plc Breakdown of Net Sales, by Segment, 2016
  • Figure 66 : Anthera Pharmaceuticals, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2016
  • Figure 67 : Anthera Pharmaceuticals, Inc. R&D Expenditure, 2013–2016

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report